Literature DB >> 11284802

Cell and cytokine profiles in nasal secretions from patients with nasal polyposis: effects of topical steroids and surgical treatment.

F Bolard1, P Gosset, C Lamblin, C Bergoin, A B Tonnel, B Wallaert.   

Abstract

BACKGROUND: Nasal polyposis (NP), a chronic inflammatory disease of the paranasal sinus mucosa, is frequently associated with asthma. Previous reports showed that surgical treatment for nasal polyps may influence asthma evolution. We hypothesized that sinus surgery may alter the cytokine network in nasal secretions.
METHODS: We evaluated the characteristics (cells and mediators) of nasal lavages in nine patients with untreated NP (group A), 17 patients treated with topical steroids (group B), 21 patients treated by nasal surgery endonasal ethmoidectomy associated with topical steroids (group C), and 12 healthy subjects (controls).
RESULTS: Percentages of both eosinophils and neutrophils were higher in NP patients than in controls. Percentages of eosinophils and interleukin-5 (IL-5) level were higher in group A than in group C and controls. There was a positive correlation between IL-5 and eosinophils. In marked contrast, IL-8, IL-10, and IL-1beta levels were significantly higher in group C than in groups A and B and controls; TNF-alpha concentration was significantly lower in group C than in groups A and B and controls; and there was a negative correlation between IL-10 and TNF-alpha. The percentage of eosinophils was higher in asthmatic patients with NP than in nonasthmatic patients. In addition, in group C, asthmatic patients also had a significantly higher level of IL-10 than nonasthmatic patients.
CONCLUSIONS: Our study demonstrates that percentages of eosinophils and neutrophils, and IL-5 level were increased in nasal secretions from untreated patients with NP. Topical steroid treatment is associated with a decrease of inflammatory cells and mediators. In marked contrast, nasal surgery is associated with marked changes, in cytokine profile in nasal secretions, that are clearly different from those of controls and topical steroid-treated NP patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284802     DOI: 10.1034/j.1398-9995.2001.00835.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  9 in total

1.  Cytokine profile in paranasal effusions in patients with chronic sinusitis using the YAMIK sinus catheter with and without betamethasone.

Authors:  Kyosuke Furukido; Sachio Takeno; Tsutomu Ueda; Koji Yajin
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-02-13       Impact factor: 2.503

2.  Antifungal immune reactivity in nasal polyposis.

Authors:  Lucia Pitzurra; Silvia Bellocchio; Angela Nocentini; Pierluigi Bonifazi; Raffaele Scardazza; Luigi Gallucci; Fabrizio Stracci; Costantino Simoncelli; Francesco Bistoni; Luigina Romani
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 3.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Short-term antibiotics treatment in patients with nasal polyps and enterotoxins producing Staphylococcus aureus strains.

Authors:  Petr Schalek; P Petrás; V Klement; A Hahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-22       Impact factor: 2.503

5.  Correlation between clinical findings and eosinophil/neutrophil ratio in patients with nasal polyps.

Authors:  S Hancer Tecimer; F Kasapoglu; U L Demir; O A Ozmen; H Coskun; O Basut
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-10       Impact factor: 2.503

Review 6.  Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.

Authors:  Robert P Schleimer
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

7.  Nasal inflammation induced by a common cold: comparison between controls and patients with nasal polyposis under topical steroid therapy.

Authors:  C Dassonville; P Bonfils; I Momas; N Seta
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-04       Impact factor: 2.124

8.  Comparison of Corticosteroids by 3 Approaches to the Treatment of Chronic Rhinosinusitis With Nasal Polyps.

Authors:  Yunyun Zhang; Hongfei Lou; Yang Wang; Ying Li; Luo Zhang; Chengshuo Wang
Journal:  Allergy Asthma Immunol Res       Date:  2019-07       Impact factor: 5.764

9.  TLR-2 expression and dysregulated human Treg/Th17 phenotype in Aspergillus flavus infected patients of chronic rhinosinusitis with nasal polyposis.

Authors:  Gargi Rai; Shukla Das; Mohammad Ahmad Ansari; Praveen Kumar Singh; Sajad Ahmad Dar; Shafiul Haque; Neelima Gupta; Sonal Sharma; Vishnampettai Ganapathysubramanian Ramachandran; Sanskriti Sharma; Charu Jain; Shipra Sharma
Journal:  Microb Cell Fact       Date:  2020-11-25       Impact factor: 5.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.